[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592888":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":10,"centralContacts":28,"locations":10,"responsibleParty":34,"collaborators":10,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":10,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":10,"overallStatus":55,"whyStopped":10,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":10},{"fullName":5,"class":6},"Haseki Training and Research Hospital","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"internal intensive care",null,"Patients hospitalized in intensive care for internal reasons",[13],"Behavioral: Glaskow coma scala, The Acute Physiology and Chronic Health Evaluation System- APACHE, Injury Severity Score- ISS)",{"label":15,"type":10,"description":16,"interventionNames":17},"surgical intensive care","Patients hospitalized in intensive care for surgical reasons",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Outpatient clinic patients","Healthy female patients admitted to gynecology outpatient clinic",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"BEHAVIORAL","Glaskow coma scala, The Acute Physiology and Chronic Health Evaluation System- APACHE, Injury Severity Score- ISS)","The uterus, endometrium and ovarian characteristics, endometrial thickness, ovarian follicle number and ovarian volume parameters, hormone panel (FSH, LH, E2, AMH), cortisol, prolactin and thyroid function tests routinely examined for ovarian reserve will be evaluated in the study.",[19,9,15],[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"emine yılmaz güler","CONTACT","905054525261","dr.emine.yilmaz@gmail.com",{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Emine Yilmaz Guler","Principal Investigator","100592888","ovarian-reserve-in-intensive-care-patients-100592888",false,"NCT06999291","Ovarian Reserve in Intensive Care Patients","Evaluation of Ovarian Reserve in Critically Ill Patients Followed in the Intensive Care Unit","Inclusion Criteria:\n\n* 18-35 years of age\n* Female patients followed in the intensive care unit for more than 24 hours for internal or surgical reasons,\n* Women whose ovarian reserve is being evaluated,\n\nExclusion Criteria:\n\n* Previous ovarian surgery, endometriosis, endometrioma,\n* History of chemotherapy, radiotherapy,\n* Ovarian cyst, malignancy and other ovarian pathologies,\n* Women with single ovary,\n* Women receiving hormone therapy,\n* Polycystic ovary syndrome,\n* Surgical intervention within the last 6 months,\n* History of drug, alcohol, substance use,\n* Women in pregnancy, puerperium, lactation,\n* History of vaccination within the last 6 months","FEMALE","18 Years","35 Years",{"count":49,"type":50},75,"ESTIMATED","OBSERVATIONAL","Gastrointestinal, pulmonary, nephrological, cardiac, neurologic and psychological effects in critically ill patients followed in the intensive care unit have been shown in the literature. However, the effects on ovarian reserve in these patients have not been sufficiently investigated and studies investigating this issue are limited in the literature. The synthesis, release frequency and amplitude of reproductive hormones change under stress. In addition, changes in ovarian homeostasis affect ovarian reserve. The aim of this study was to evaluate ovarian reserve in critically ill patients followed up in the intensive care unit.",[54],"Anti-Mullerian Hormone Deficiency","NOT_YET_RECRUITING","2025-05-22",{"date":58,"type":59},"2025-05-31","ACTUAL",{"date":61,"type":50},"2025-06-15",{"date":63,"type":50},"2025-11-15",{"name":5,"class":6}]